- Home
- FPH vs ALT Comparison
FPH vs ALT Comparison
Compare FPH & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FPH
- ALT
- Stock Information
- Founded
- FPH 2009
- ALT 1997
- Country
- FPH United States
- ALT United States
- Employees
- FPH N/A
- ALT N/A
- Industry
- FPH Real Estate
- ALT Biotechnology: Pharmaceutical Preparations
- Sector
- FPH Finance
- ALT Health Care
- Exchange
- FPH Nasdaq
- ALT Nasdaq
- Market Cap
- FPH 390.0M
- ALT 292.0M
- IPO Year
- FPH 2017
- ALT N/A
- Fundamental
- Price
- FPH $5.68
- ALT $3.83
- Analyst Decision
- FPH
- ALT Strong Buy
- Analyst Count
- FPH 0
- ALT 6
- Target Price
- FPH N/A
- ALT $17.40
- AVG Volume (30 Days)
- FPH 150.3K
- ALT 3.0M
- Earning Date
- FPH 10-16-2025
- ALT 08-12-2025
- Dividend Yield
- FPH N/A
- ALT N/A
- EPS Growth
- FPH 46.82
- ALT N/A
- EPS
- FPH 1.08
- ALT N/A
- Revenue
- FPH $197,429,000.00
- ALT $20,000.00
- Revenue This Year
- FPH N/A
- ALT N/A
- Revenue Next Year
- FPH N/A
- ALT $761,880.20
- P/E Ratio
- FPH $5.28
- ALT N/A
- Revenue Growth
- FPH N/A
- ALT N/A
- 52 Week Low
- FPH $3.10
- ALT $2.90
- 52 Week High
- FPH $6.71
- ALT $11.16
- Technical
- Relative Strength Index (RSI)
- FPH 56.60
- ALT 51.79
- Support Level
- FPH $5.51
- ALT $3.35
- Resistance Level
- FPH $5.77
- ALT $3.66
- Average True Range (ATR)
- FPH 0.14
- ALT 0.19
- MACD
- FPH 0.04
- ALT 0.07
- Stochastic Oscillator
- FPH 95.83
- ALT 86.18
About FPH Five Point Holdings LLC
Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its three reportable segments are Valencia, San Francisco, and Great Park. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.
About ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.